DCAT week – one of the world´s most important pharma events – has just come to an end. It was four very successful and inspiring days for TIEFENBACHER GROUP in New York City. What a pleasure to present our latest product portfolio and innovations and to connect with existing and potential new partners. Check out our short video to get some impressions!
About TIEFENBACHER GROUP – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our goal is to improve patients’ lives by making pharmaceuticals more affordable, more available and better than ever before.
For further information about our better healthcare solution and in-house capabilities to develop and commercialize pharmaceuticals products including high-potent for global markets please contact Tiefenbacher Group: info@aet.eu
